Bharat Parenterals Limited (BOM:541096)
India · Delayed Price · Currency is INR 1,315.60
-33.85 (-2.51%)
At close: Aug 17, 2026
Bharat Parenterals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 3,232 | 3,454 | 3,404 | 2,612 | 2,180 | 2,120 |
Other Revenue | - | - | - | 0 | 13.22 | 3.17 |
| 3,232 | 3,454 | 3,404 | 2,612 | 2,193 | 2,123 | |
Revenue Growth | -11.19% | 1.48% | 30.31% | 19.11% | 3.28% | 2.46% |
Cost of Revenue | 1,689 | 1,914 | 1,895 | 1,614 | 1,394 | 1,379 |
Gross Profit | 1,543 | 1,540 | 1,508 | 998.57 | 799.43 | 744.1 |
Selling, General & Admin | 708.21 | 672.79 | 512.14 | 245.37 | 187.63 | 159.33 |
Other Operating Expenses | 729.13 | 709.4 | 954.62 | 480.31 | 354.64 | 273.18 |
Operating Expenses | 1,781 | 1,725 | 1,820 | 815.88 | 601.1 | 499.11 |
Operating Income | -237.58 | -184.34 | -311.49 | 182.69 | 198.33 | 244.99 |
Interest Expense | -113.02 | -125.35 | -119.17 | -31.81 | -21.86 | -9.67 |
Interest & Investment Income | - | - | 37.96 | 4.97 | 3.38 | 16.76 |
Currency Exchange Gain (Loss) | - | - | 61.9 | 33.3 | 46.99 | 13.89 |
Other Non Operating Income (Expenses) | 95.96 | 95.45 | -0.72 | -1.17 | 6.12 | 13.87 |
EBT Excluding Unusual Items | -254.63 | -214.23 | -331.52 | 187.98 | 232.96 | 279.84 |
Gain (Loss) on Sale of Investments | - | - | - | -0.44 | 3.43 | 11.25 |
Gain (Loss) on Sale of Assets | - | - | -9.76 | -0.4 | -0.91 | -7.4 |
Pretax Income | -254.63 | -214.23 | -339.51 | 187.22 | 235.47 | 283.69 |
Income Tax Expense | 45.33 | 58.82 | 97.25 | 82.07 | 78.32 | 70.65 |
Earnings From Continuing Operations | -299.96 | -273.06 | -436.75 | 105.14 | 157.15 | 213.04 |
Minority Interest in Earnings | 145.89 | 191.18 | 310.49 | 40.03 | - | - |
Net Income | -154.07 | -81.88 | -126.26 | 145.17 | 157.15 | 213.04 |
Net Income to Common | -154.07 | -81.88 | -126.26 | 145.17 | 157.15 | 213.04 |
Net Income Growth | - | - | - | -7.62% | -26.24% | 4.49% |
Shares Outstanding (Basic) | - | 4 | 7 | 6 | 6 | 6 |
Shares Outstanding (Diluted) | - | 4 | 7 | 6 | 6 | 6 |
Shares Change | - | -38.20% | 12.58% | 0.82% | 0.60% | 0.19% |
EPS (Basic) | - | -20.22 | -19.26 | 24.94 | 27.21 | 37.11 |
EPS (Diluted) | - | -20.22 | -19.26 | 24.94 | 27.21 | 37.11 |
EPS Growth | - | - | - | -8.37% | -26.67% | 4.29% |
Free Cash Flow | - | -15.71 | -563.3 | -1,090 | -699.37 | -268.38 |
Free Cash Flow Per Share | - | -3.88 | -85.95 | -187.24 | -121.11 | -46.75 |
Dividend Per Share | - | 1.000 | 1.000 | 1.000 | 0.750 | - |
Dividend Growth | - | 0% | 0% | 33.33% | - | - |
Gross Margin | 47.75% | 44.59% | 44.32% | 38.23% | 36.45% | 35.04% |
Operating Margin | -7.35% | -5.34% | -9.15% | 6.99% | 9.04% | 11.54% |
Profit Margin | -4.77% | -2.37% | -3.71% | 5.56% | 7.17% | 10.03% |
Free Cash Flow Margin | - | -0.46% | -16.55% | -41.73% | -31.89% | -12.64% |
EBITDA | 102.25 | 158.17 | 41.73 | 272.89 | 257.15 | 311.6 |
EBITDA Margin | 3.16% | 4.58% | 1.23% | 10.45% | 11.73% | 14.67% |
D&A For EBITDA | 339.83 | 342.51 | 353.22 | 90.21 | 58.82 | 66.61 |
EBIT | -237.58 | -184.34 | -311.49 | 182.69 | 198.33 | 244.99 |
EBIT Margin | -7.35% | -5.34% | -9.15% | 6.99% | 9.04% | 11.54% |
Effective Tax Rate | - | - | - | 43.84% | 33.26% | 24.90% |
Revenue as Reported | 3,328 | 3,550 | 3,520 | 2,659 | 2,297 | 2,198 |
Advertising Expenses | - | - | 15.51 | 17.5 | 7.67 | 6.23 |